The sensitivity of CD24 for the detection of CRC was 80.0% (95% CI, 63.1–91.6%) and for adenoma was 89.2% (95% CI, 74.6–97%), with a similar specificity to that obtained in the previously analyzed study group, 75.3% (95% CI, 64.2–84.4%) and 71.4% (95% CI, 60.0–97.0%) for CRC and adenoma, respectively (Table 2 and Figures 2(c) and 2(d)). This evidence concerns the gene CD24 and adenoma.